Drug class
Hepatitis B vaccines constitute an established pharmacologic class of active immunizing agents designed to prevent infection caused by the hepatitis B virus (HBV). Read more about Hepatitis B Vaccine
24 drugs in this class 6 manufacturers
Hepatitis B vaccines constitute an established pharmacologic class of active immunizing agents designed to prevent infection caused by the hepatitis B virus (HBV).
These biological products primarily utilize recombinant hepatitis B surface antigen (HBsAg) to stimulate an active immune response, inducing the production of specific neutralizing anti-HBs antibodies and conferring long-term protection against the virus.
The class is indicated for pre-exposure immunization in infants, children, adolescents, and adults, as well as for post-exposure prophylaxis following occupational, perinatal, or mucosal exposures.
By preventing acute HBV infection, these vaccines effectively avert the progression to chronic hepatitis B, cirrhosis, and hepatocellular carcinoma.
Hepatitis B vaccines constitute an established pharmacologic class of active immunizing agents designed to prevent infection caused by the hepatitis B virus (HBV) These biological products primarily utilize recombinant hepatitis B surface antigen (HBsAg) to stimulate an active immune response, inducing the production of specific neutralizing anti-HBs antibodies and conferring long-term protection against the virus
Hepatitis B vaccines constitute an established pharmacologic class of active immunizing agents designed to prevent infection caused by the hepatitis B virus (HBV) These biological products primarily utilize recombinant hepatitis B surface antigen (HBsAg) to stimulate an active immune response, inducing the production of specific neutralizing anti-HBs antibodies and conferring long-term protection against the virus By preventing acute HBV infection, these vaccines effectively avert the progressio...
These biological products primarily utilize recombinant hepatitis B surface antigen (HBsAg) to stimulate an active immune response, inducing the production of specific neutralizing anti-HBs antibodies and conferring long-term protection against the virus
The class is indicated for pre-exposure immunization in infants, children, adolescents, and adults, as well as for post-exposure prophylaxis following occupational, perinatal, or mucosal exposures
The class is indicated for pre-exposure immunization in infants, children, adolescents, and adults, as well as for post-exposure prophylaxis following occupational, perinatal, or mucosal exposures
By preventing acute HBV infection, these vaccines effectively avert the progression to chronic hepatitis B, cirrhosis, and hepatocellular carcinoma
Following a drug class requires a free Physicians Office Resource account.
